Currently, Richard is the technical advisor for SaniSure. For 25 years he served as CEO and co-owner of Cellon, located in Luxembourg. Cellon was a leading provider of vaccine production and bioprocessing solutions. He received his BSc in cell and molecular biology from the University of Essex in the UK. An accomplished innovator, he developed both PharmaTainer™ and contributed to Roller Cell 40 technologies. His expertise spans mammalian cell culture processes, 3D tissue culture, tissue engineering, sterile liquid handling systems, and vacuum measurement technologies. Richard Fry’s contributions have significantly advanced bioprocess manufacturing and sterile liquid handling systems. He was also involved in multiple EU-funded research projects, acting as the project lead and coordinator.